PPAR antagonists (Georgetown University/Georgetown University Office of Technology Commercialization)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NamePPAR antagonists (Georgetown University/Georgetown University Office of Technology Commercialization)

Drug Alias Nameperoxisome proliferator-activated receptors antagonists (Georgetown University/Georgetown University Office of Technology Commercialization)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionPeroxisome proliferator activated receptor inhibitors

TargetsPeroxisome proliferator activated receptor

Therapy Area/IndicationsObesityDiabetes MellitusMetabolic Diseases +[5]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesGeorgetown University

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesGeorgetown University

Active IndicationsN/A

Inactive IndicationsObesityDiabetes MellitusMetabolic Diseases +[5]

Other Information

ATC CodeN/A